When will prevention of HTLV-III infection be possible? NLM AIDSLINE Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


When will prevention of HTLV-III infection be possible?

Vaccine. 1984 Sep;2(3):171-2. Unique Identifier : AIDSLINE MED/85170405
Tedder R; Weiss R

Abstract: Over the last five years, the pattern and prevalence of the Acquired Immune Deficiency Syndrome (AIDS) has taxed microbiologists. The disease has increasingly looked like the result of a transmissible agent which though of low infectivity, has a predilection for certain well-defined social groups. Homosexual men are among the most commonly affected but drug addicts and haemophiliacs are also at risk. The existence of the disease in central Africa suggests also that there may be a natural focus perhaps as the result of interaction between the human population and enzootic animal virus. Nevertheless, the origin of the disease remains obscure.
Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY/*PREVENTION & CONTROL Antibodies, Viral/ANALYSIS Blood Donors Human Serodiagnosis Viral Vaccines/IMMUNOLOGY JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/immunology/KWDprevention&controlantibodies,viral/analysisblooddonorshumanserodiagnosisviralvaccines/immunologyjournalarticle
850730
M8570165

Copyright © 1985 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .